CureVac N.V. (CVAC) Prices 5M Share Follow-On Common Offering at $90/Sh

CureVac N.V. (NASDAQ: CVAC) announced today the pricing of its follow-on public offering of 5,000,000 common shares at a public offering price of $90.00 per common share, for total gross proceeds of approximately $450 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 750,000 common shares at the public offering price, less underwriting discounts and commissions. All of the common shares are being offered by CureVac. The offering is expected to close on February 1, 2021, subject to satisfaction of customary closing conditions.

BofA Securities, Jefferies and Evercore ISI are acting as joint book-running managers for the offering. UBS Investment Bank, Guggenheim Securities, Berenberg and Kempen & Co are acting as passive book running managers for the offering.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission ("SEC") on January 27, 2021. The offering is being made only by means of a prospectus.

You May Also Be Interested In

• Andersen Group launches secondary offering of 4.28M shares
• BigBear.ai adds retired Lt. Gen. Sean Gainey to its board
• Karman Line Acquisition prices $200M IPO on Nasdaq